linzess.com — September 2026 traffic, keywords & AI visibility

Search engines send linzess.com an estimated 92,400 visits a month. Effectively all of it is organic — about 92,400 visits from unpaid results. Spread across 4,544 ranking keywords, that averages roughly 20 organic visits per keyword.

linzess.com scores 67 out of 100 on our AI visibility scale, grade C. It takes full marks for LLMS.txt and Structured data. The biggest gap is SEO health, at 0 of 20 points (0/100), worth 20 points if closed. It also loses points on Crawlability (0/10) and Company profile (22/25).

The llms.txt on linzess.com runs to 81 lines (3,845 characters) across 12 sections, last generated in May 2026. It introduces the site as "Linzess - Prescription Treatment for IBS-C & Chronic Constipation". It tells AI engines the business works in Pharmaceuticals, Gastroenterology and Patient Support Services. It describes 5 products, with prices such as LINZESS 72 mcg at Contact pharmacy / ~$500 retail, LINZESS 145 mcg at Contact pharmacy / ~$500 retail and LINZESS 290 mcg at Contact pharmacy / ~$500 retail. Services it lists include Savings & Support Program, From the Gut Stories, FAQs & Education and HCP Resources. The audience it names is IBS-C and CIC patients, aged 6+ (North America, EU). Technologies it mentions include HTTPS Secure, Responsive Viewport and Static Content Delivery. The keywords it claims start with "linzess", "ibs-c", "chronic constipation" and "cic".

# Linzess - Prescription Treatment for IBS-C & Chronic Constipation

## About
Linzess delivers targeted relief for adults and kids dealing with irritable bowel syndrome with constipation and chronic idiopathic constipation. The once-daily capsule boosts fluid in the intestines to soften stool and promote regularity without the laxative habit. Backed by clinical trials showing rapid onset, it tackles both symptoms and quality of life impacts. The brand offers practical tools like savings programs that cap copays at $30 for many insured patients. Educational content demystifies gut health conditions often shrouded in embarrassment. 'From the Gut' shares authentic patient journeys to build community. Doctors rely on its predictable profile in practice. It's not just a pill—it's a pathway to normalcy for millions affected yearly. Support FAQs address real-world questions from dosing to side effects. Linzess positions itself as the go-to guanylate cyclase agonist in GI care. Ongoing studies affirm its role in long-term management. The site guides users to HCP discussions and pharmacy options. Relief starts with one dose, but commitment yields lasting results. Patient resources extend beyond the Rx to lifestyle tips. In a field of generics and alternatives, Linzess holds strong market share. It empowers those silenced by chronic discomfort. Accessibility through copay cards removes f

Google lists linzess.com for about 4,544 keywords, which together bring an estimated 92,400 organic visits a month.

The latest technical audit of linzess.com scored 0 out of 100 overall. The audit makes 8 recommendations in all.

Linzess's company profile names constipation.com, ibsrelief.com, healthline.com and webmd.com as competitors. Its own llms.txt adds mayoclinic.org and drugs.com. Outside its market, the domains ranked closest to it in our worldwide ranking are revolution-energetique.com, servmask.com, travismanion.org and kmlink.com.my.

constipation.com

ibsrelief.com

healthline.com

webmd.com

mayoclinic.org

drugs.com